Health Care & Life Sciences » Biotechnology | Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
81,394.00
36,970.00
38,326.00
92,163.00
21,337.00
17,970
Cost of Goods Sold (COGS) incl. D&A
10,281.00
12,339.50
13,175.00
-
-
-
Gross Income
71,113.00
24,630.50
25,151.00
-
-
-
SG&A Expense
94,048.00
129,903.50
124,377.00
86,317.00
97,051.00
158,994
EBIT
22,935.00
105,273.00
99,226.00
-
79,992.00
144,783
Unusual Expense
10,150.00
4,418.00
3,498.00
6,115.00
11,975.00
-
Non Operating Income/Expense
352.00
47,179.00
1,415.00
815.00
1,740.00
2,872
Interest Expense
7,091.00
6,915.00
6,828.00
6,512.00
6,119.00
5,695
Pretax Income
19,435.00
60,508.00
107,979.00
12,300.00
95,854.00
138,834
Consolidated Net Income
19,435.00
60,508.00
107,979.00
12,300.00
95,854.00
28,569
Net Income
19,435.00
60,508.00
107,979.00
11,920.00
94,529.00
28,569
Net Income After Extraordinaries
19,435.00
60,508.00
107,979.00
1,324.00
97,651.00
27,739
Net Income Available to Common
19,435.00
60,508.00
107,979.00
22,516.00
91,407.00
30,124
EPS (Basic)
0.90
2.80
4.50
9.30
2.77
0.62
Basic Shares Outstanding
21,810.40
21,973.40
24,067.10
2,431.30
32,990.00
47,041
EPS (Diluted)
0.89
2.75
4.49
9.26
2.77
0.62
Diluted Shares Outstanding
21,810.40
21,973.40
24,067.10
2,431.30
32,990.00
47,041
EBITDA
14,733.00
96,112.00
89,184.00
5,846.00
75,714.00
141,024
Non-Operating Interest Income
89.00
83.00
158.00
290.00
492.00
8,772
Minority Interest Expense
-
-
-
380.00
1,325.00
-

About Arena Pharmaceuticals

View Profile
Address
6154 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.arenapharm.com
Updated 07/08/2019
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.